164 related articles for article (PubMed ID: 30673295)
61. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
[TBL] [Abstract][Full Text] [Related]
62. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
63. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
64. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.
Fuller CD; Wang SJ; Choi M; Czito BG; Cornell J; Welzel TM; McGlynn KA; Luh JY; Thomas CR
Cancer; 2009 Nov; 115(22):5175-83. PubMed ID: 19637356
[TBL] [Abstract][Full Text] [Related]
65. Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
Ryan JF; Groot VP; Rosati LM; Hacker-Prietz A; Narang AK; McNutt TR; Jackson JF; Le DT; Jaffee EM; Zheng L; Laheru DA; He J; Pawlik TM; Weiss MJ; Wolfgang CL; Herman JM
Ann Surg Oncol; 2018 Jan; 25(1):280-289. PubMed ID: 29063299
[TBL] [Abstract][Full Text] [Related]
66. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
[TBL] [Abstract][Full Text] [Related]
67. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
68. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
[TBL] [Abstract][Full Text] [Related]
69. Radiotherapy and multimodality management of cholangiocarcinoma.
Urego M; Flickinger JC; Carr BI
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):121-6. PubMed ID: 10219804
[TBL] [Abstract][Full Text] [Related]
70. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
71. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
72. Role of liver transplantation in the treatment of cholangiocarcinoma.
Singal A; Welling TH; Marrero JA
Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
[TBL] [Abstract][Full Text] [Related]
73. Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
Pérez-Montero H; Godino O; Lozano A; Asiáin L; Martínez I; Sánchez JJ; de BlasFernández R; Fernández E; Stefanovic M; García N; Martínez J; Guedea F; Navarro-Martin A
Clin Transl Oncol; 2022 Feb; 24(2):276-287. PubMed ID: 34342817
[TBL] [Abstract][Full Text] [Related]
74. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
[TBL] [Abstract][Full Text] [Related]
75. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wo JY; Dawson LA; Zhu AX; Hong TS
Surg Oncol Clin N Am; 2014 Apr; 23(2):353-68. PubMed ID: 24560114
[TBL] [Abstract][Full Text] [Related]
76. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
77. Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1).
Arcelli A; Guido A; Buwenge M; Simoni N; Mazzarotto R; Macchia G; Deodato F; Cilla S; Bonomo P; Scotti V; Belgioia L; Tolento G; Cellini F; Grassi E; DI Marco M; Casadei R; Morganti AG; Cammelli S
Anticancer Res; 2020 Jan; 40(1):465-472. PubMed ID: 31892602
[TBL] [Abstract][Full Text] [Related]
78. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.
Dewas S; Bibault JE; Mirabel X; Fumagalli I; Kramar A; Jarraya H; Lacornerie T; Dewas-Vautravers C; Lartigau E
Radiat Oncol; 2012 Oct; 7():166. PubMed ID: 23050794
[TBL] [Abstract][Full Text] [Related]
79. Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.
Moureau-Zabotto L; Turrini O; Resbeut M; Raoul JL; Giovannini M; Poizat F; Piana G; Delpero JR; Bertucci F
BMC Cancer; 2013 Dec; 13():568. PubMed ID: 24299517
[TBL] [Abstract][Full Text] [Related]
80. Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review.
Scirocco E; Cellini F; Zamagni A; Macchia G; Deodato F; Cilla S; Strigari L; Buwenge M; Rizzo S; Cammelli S; Morganti AG
Front Oncol; 2021; 11():748200. PubMed ID: 34868948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
